Company intelligence / Profile preview

Tencent

Shenzhen, Guangdong, Chinatencent.com ↗

Ownership: Public · 700
Employees: ~112000
Development stage: Commercial

Overview

Tencent is a leading Chinese technology conglomerate with significant activity in healthcare through digital platforms (e.g., AI-powered diagnostics) and strategic investments in innovative drug development startups across small molecules, RNAi therapies, cell therapies and more. Its AIMIS system has been clinically validated at over 100 hospitals for medical image analysis with high accuracy rates for several cancers and eye diseases. As an investor since 2019–2025 it has backed dozens of biotech/pharma startups at various clinical stages.

Modalities: Artificial intelligence-based diagnosticsCloud computing
Industry: Digital Health Medical Devices

Partnerships

Sinovent BioPharmaSanegene BioNeurodawn PharmaceuticalGenscript BiotechEvopoint BiosciencesWeSure Internet Insurance Ltd.

Beyond the preview

Go deeper on Tencent.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tencent.

Explore the full profile